v3.25.1
Financial Instruments and Fair Value Measurements - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity securities without readily determinable fair value, impairment loss, annual amount $ 0 $ 0 $ 0 $ 1,800,000  
Equity securities without readily determinable fair value, amount 54,600,000   54,600,000   $ 54,600,000
Auction rate security | Fair Value, Measurements, Recurring          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Unrealized (loss) gain on investments 0 0 0 0  
Level 1 | Investment in marketable equity security          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Unrealized (loss) gain on investments (1,300,000) $ (1,500,000) (200,000) $ (2,300,000)  
Level 2 | Fair Value, Measurements, Recurring          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair value of debt outstanding 107,000,000.0   107,000,000.0   $ 476,400,000
Level 2 | Fair Value, Measurements, Recurring | Convertible Senior Notes Due 2029 | Convertible Notes Payable          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair value of company's convertible debt 1,689,500,000   1,689,500,000    
Level 2 | Fair Value, Measurements, Recurring | Convertible Senior Notes Due 2028 | Convertible Notes Payable          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair value of company's convertible debt $ 730,400,000   $ 730,400,000